SPONSOR
Seagen, a wholly owned subsidiary of Pfizer
Total Trials
3
Recruiting
3
Phases
Phase 1
Conditions studied: Carcinoma, Non-Small-Cell LungSquamous Cell Carcinoma of the Head and NeckEsophageal Squamous Cell CarcinomaTriple Negative Breast NeoplasmsGastric CancerEndometrial CancerPancreatic AdenocarcinomaHepatocellular CarcinomaColorectal NeoplasmsStomach Neoplasms
Clinical Trials by Seagen, a wholly owned subsidiary of Pfizer
NCT05208762 Phase 1
Recruiting
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Carcinoma, Non-Small-Cell Lung
NCT06131840 Phase 1
Recruiting
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Colorectal Neoplasms
NCT04389632 Phase 1
Recruiting
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Carcinoma, Non-Small Cell Lung
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology